ANVS405 / Annovis Bio - LARVOL DELTA

Annovis Bio Receives European Patent for Method of Treating Acute Nerve and Brain Insults (Annovis Bio Press Release) - "Annovis Bio...today announced the European Patent Office (EPO) granted the Company's patent for a method of treating acute nerve and brain injuries by administering ANVS405 after the injury. 'This new patent, covering acute indications, joins our two patents covering our primary disease targets, AD and PD, which both originate from a patent family that claims ANVS401 for the treatment of neurodegenerative diseases,...We expect to receive additional patent allowances in the future, and we will continue to provide further updates as we execute on this process.'"

Patent • Alzheimer's Disease • CNS Disorders • Parkinson's Disease